{
  "title": "Paper_100",
  "abstract": "Cancer Immunol Res Cancer Immunol Res 319 nihpa Cancer immunology research 2326-6066 2326-6074 pmc-is-collection-domain yes pmc-collection-title NIHPA Author Manuscripts PMC12489179 PMC12489179.1 12489179 12489179 NIHMS2110917 40828448 10.1158/2326-6066.CIR-25-0313 NIHMS2110917 NIHPA2110917 1 Article Reprogramming CD8 + N Azevedo Catarina M. 1 2 Xie Bingxian 3 4 Gunn William G. 3 4 Peralta Ronal M. 3 4 Dantas Carolina S. 1 2 Fernandes-Mendes Henrique 2 9 Joshi Supriya 3 4 Dean Victoria 3 4 Almeida Pedro 1 Wilfahrt Drew 3 4 Mendes Nuno 1 Portero Julian López 5 6 7 Poves Carmen 7 8 Fernández-Aceñero María Jesús 5 6 Marcos-Pinto Ricardo 2 9 Fernandes Ângela 1 * Delgoffe Greg M. 3 4 * Pinho Salomé S. 1 2 10 11 * 1 2 3 4 5 6 7 8 9 10 * These authors contributed equally/Senior authors AUTHOR CONTRIBUTIONS Conceptualization: C.M.A., Â.F., G.M.D., and S.S.P.; methodology: C.M.A., B.X., W.G., R.M.P., C.S.D., H.M.-F., S.J., V.D., P.A., D.W. and Â.F.; investigation: C.M.A., B.X., W.G., R.M.P., C.S.D., H.M.-F., S.J., V.D., P.A., D.W., N.M. and Â.F.; Resources: J.L.P., C.P., M.J.F.-A. and R. M.-P.; supervision: Â.F., G.M.D., and S.S.P.; funding acquisition: Â.F., G.M.D., and S.S.P.; writing – original draft: C.M.A., Â.F., G.M.D., and S.S.P.; writing – review and editing: C.M.A., B.X., W.G., R.M.P., C.S.D., H.M.-F., S.J., V.D., P.A., D.W., N.M., J.L.P., C.P., M.J.F.-A., R. M.-P., Â.F., G.M.D., and S.S.P. 11 salomep@i3s.up.pt DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST: A provisional patent application related with the discovery underlying this study was submitted (20242006681619). The authors declare no other potential conflicts of interest. 01 10 2025 13 10 498135 1655 1673 25 09 2025 02 10 2025 03 10 2025 03 10 2025 T-cell therapies have transformed cancer treatment. While surface glycans have been shown to play critical roles in regulating T-cell development and function, whether and how the glycome influences T cell–mediated tumor immunity remains an area of active investigation. In this study, we show that the intratumoral T-cell glycome is altered early in human colorectal cancer, with substantial changes in branched N + N Mgat5 Mgat5 + MGAT5 MGAT5 MGAT5 N + T cell N branched N MGAT5 Tumor microenvironment T cell immune response T cell exhaustion Immunotherapy CAR-T cells pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access no pmc-prop-olf no pmc-prop-manuscript yes pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes ",
  "metadata": {
    "Title of this paper": "Reprogramming CD8",
    "Journal it was published in:": "Cancer immunology research",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12489179/"
  }
}